FUJIFILM Holdings Corporation (TYO:4901)
Japan
· Delayed Price · Currency is JPY | Market Cap | 3.60T |
| Revenue (ttm) | 3.13T |
| Net Income (ttm) | 251.29B |
| Shares Out | 1.20B |
| EPS (ttm) | 208.45 |
| PE Ratio | 14.33 |
| Forward PE | 13.62 |
| Dividend | 60.00 (1.98%) |
| Ex-Dividend Date | Mar 28, 2025 |
| Volume | 3,469,100 |
| Average Volume | 3,242,685 |
| Open | 3,021.00 |
| Previous Close | 3,036.00 |
| Day's Range | 2,973.00 - 3,023.00 |
| 52-Week Range | 2,743.50 - 3,999.00 |
| Beta | 0.18 |
| RSI | 39.91 |
| Earnings Date | May 8, 2025 |
About FUJIFILM Holdings
FUJIFILM Holdings Corporation develops, manufactures, sells, and services imaging, healthcare, materials, and business innovation solutions worldwide. The company’s Healthcare segment provides products and services, such as medical devices, biomedical contract development and manufacturing organization, pharmaceutical, regenerative medicine, and cosmetics and supplements in the areas of prevention, diagnosis, and treatment. Its Materials segment offers inkjet digital presses and printing plates for printing industries, as well as industrial ink... [Read more]
Financial Performance
In 2023, FUJIFILM Holdings's revenue was 2.96 trillion, an increase of 3.56% compared to the previous year's 2.86 trillion. Earnings were 243.33 billion, an increase of 10.95%.
Financial StatementsNews
Fujifilm Partners with Us2.ai to Provide AI-Automated Echocardiography Analysis for Cardiologists and Sonographers Across the Nation
LEXINGTON, Mass.--(BUSINESS WIRE)--FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging solutions and Us2.ai, a leader in AI-automated echocardiography sol...
.jpg)
Verizon Satellite Messaging, a Retro Console, and Velotric's EbikeHeres Your Gear News of the Week
Plus: Analogue delays its Nintendo 64 console, Fujifilm unveils a medium format camera, and Microsoft's Adaptive Joystick game controller goes on sale.
Fujifilm Hosts “Digital Disruption Reveal” Event at its North American Graphics Headquarters
HANOVER PARK, Ill., March 18, 2025 (GLOBE NEWSWIRE) -- FUJIFILM North America Corporation, Graphic Communication Division, today announces that it is hosting a “Digital Disruption Reveal” event at its...
Fujifilm Announces Commercialization of the EN-840T Double Balloon Enteroscopy (DBE) Scope, a Unique Endoscopic Imaging Technology for Diagnosis and Treatment in the Small Intestine
New DBE scope is designed for endoscopists and GI physicians that specialize in small bowel diseases and disorders New DBE scope is designed for endoscopists and GI physicians that specialize in small...
Fujifilm Partners with Tiger Health Technology to Enhance Digital Pathology Storage and Access
Lexington, MA, and Las Vegas, NV, March 03, 2025 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Americas Corporation, a leading provider of enterprise imaging and informatics solutions, today announced a new...
Fujifilm Awarded Exclusive Defense Logistics Agency (DLA) Contract for its Surgical C-Arm Systems
Fujifilm will outfit multiple branches of the U.S. military and their medical treatment facilities under four year contract Fujifilm will outfit multiple branches of the U.S. military and their medica...
Fujifilm and EndoSim Partner to Expand Access to Advanced Endoscopy Training
Fujifilm transfers its exclusive U.S. distributorship of endoscopy simulation model EndoGel to EndoSim Fujifilm transfers its exclusive U.S. distributorship of endoscopy simulation model EndoGel to En...
FUJIFILM records revenue of ¥2,327.5B for nine months ended December 31
Fujifilm and the Americas Printing Association Network Expand Relationship with a Buying Power Program
HANOVER PARK, Ill., Jan. 30, 2025 (GLOBE NEWSWIRE) -- FUJIFILM North America Corporation, Graphic Communication Division, today announces that it is expanding its long existing relationship with the A...
Welcome Change with FUJIFILM Business Innovation
True digital transformation redefines the future of information and human potential.
/cdn.vox-cdn.com/uploads/chorus_asset/file/25840200/fujifilm_instax1.jpg)
Fujifilm’s new hybrid instant camera features its widest lens yet
The Fujifilm Instax Wide Evo Hybrid Instant Camera is expected to be available starting in February 2025 for $349.95. | Image: Fujifilm Fujifilm has announced a new hybrid instant camera coming to its...
FUJIFILM Irvine Scientific Sells its Medical Media Business to Astorg
SANTA ANA, Calif.--(BUSINESS WIRE)--FUJIFILM Irvine Scientific, Inc., a global leader in the innovation and manufacture of cell culture solutions for the life science and medical markets, today announ...
The Instant Evo-lution Continues: Fujifilm Introduces instax WIDE Evo™ Hybrid Instant Camera
VALHALLA, N.Y., Jan. 20, 2025 (GLOBE NEWSWIRE) -- FUJIFILM North America Corporation, Imaging Division, today announced the latest addition to its popular instax™ line of instant cameras and smartphon...
/cdn.vox-cdn.com/uploads/chorus_asset/file/25839317/fujinon1.jpg)
Fujifilm’s new stabilized binoculars deliver even more zoom
Fujifilm has added two new models to its Techno-Stabi binoculars line with stabilization and increased magnification. | Image: Fujifilm Fujifilm has announced two new additions to its flagship Techno-...
Fujifilm: Growing More Niches, At Scale
Discover why Fujifilm is a promising investment opportunity with a strong foundation and growth potential in healthcare and materials sectors.
A Dynamic Duo: Fujifilm Introduces FUJINON TECHNO-STABI TS-L1640 and FUJINON TECHNO-STABI TS-L2040 Binoculars
VALHALLA, N.Y., Jan. 15, 2025 (GLOBE NEWSWIRE) -- FUJIFILM North America Corporation, Optical Devices Division today announced the introductions of FUJINON TECHNO-STABI TS-L1640 (TS-L1640) and FUJINON...
Fujifilm Celebrates 8 New Recipients of Fujifilm Fellowships at Harvard Medical School
Multi-year program advancing translational medical science research and education Multi-year program advancing translational medical science research and education
Fujifilm Granted Authority to Operate its ASPIRE Cristalle Aquisition Workflow System (AWS) on U.S. Department of Defense Networks
With ASPIRE Cristalle AWS, organizations within the DoD network will be able to securely acquire and access patients' mammography images With ASPIRE Cristalle AWS, organizations within the DoD network...
Fujifilm Introduces New REVORIA PRESS Products with Available Specialty Color Capabilities
New presses enable customers to utilize vibrant print applications to enhance productivity through Fujifilm's next generation technology New presses enable customers to utilize vibrant print applicati...
Fujifilm to Highlight the Speed of Synapse VX for Mammography and Cardiology, Cloud-Native Architecture and AI-Driven Workflows at RSNA 2024
Synapse PACS' Viewer eXtension's (VX) powerful speed helps increase productivity and diagnostic confidence for both the inpatient and outpatient markets Synapse PACS' Viewer eXtension's (VX) powerful ...
Fujifilm to Debut Several New Leading-Edge Medical Innovations at the RSNA 2024 Conference
Advancements across multiple modalities deliver state-of-the-art imaging, improve clinical workflows and enhance patient outcomes Advancements across multiple modalities deliver state-of-the-art imagi...
FUJIFILM Diosynth Biotechnologies Celebrates the Expansion Completion at its California Cell Therapy Facility
Celebration also includes achieving EMA regulatory issuance of GMP certification at the site Celebration also includes achieving EMA regulatory issuance of GMP certification at the site
New DeepInsight ‘the next stage' by FUJIFILM
Explore the depths of ultrasound for early diagnosis. RATINGEN, Germany, Nov. 09, 2024 (GLOBE NEWSWIRE) -- FUJIFILM Healthcare Europe is proud to launch the next stage of DeepInsight, an innovative ul...
FUJIFILM Holdings Corporation 2024 Q2 - Results - Earnings Call Presentation
The following slide deck was published by FUJIFILM Holdings Corporation in conjunction with their 2024 Q2 earnings call.
Fujifilm signs multiple MoUs during second edition of Global Health Exhibition
Reinforcing commitment to saudi arabia and paving the way for a robust future